Predictors of major bleeding in patients with atrial fibrillation treated with rivaroxaban in XANTUS: findings from a real-world prospective study

被引:0
|
作者
Kirchhof, P. [1 ,2 ]
Haas, S. [3 ]
Amarenco, P. [4 ,5 ]
Hess, S. [6 ]
Kuhls, S. [7 ]
Van Eickels, M. [8 ]
Turpie, A. G. G. [9 ]
Camm, A. J. [10 ]
机构
[1] Univ Birmingham, Inst Cardiovasc Sci, UHB Hosp NHS Trust, Birmingham, W Midlands, England
[2] Univ Birmingham, Inst Cardiovasc Sci, Sandwell & West Birmingham Hosp NHS Trust, Birmingham, W Midlands, England
[3] Vasc Ctr, Munich, Germany
[4] Paris Diderot Sorbonne Univ, Dept Neurol, Paris, France
[5] Paris Diderot Sorbonne Univ, Stroke Ctr, Paris, France
[6] Bayer Healthcare Co Ltd, Med Affairs, Beijing, Peoples R China
[7] Bayer Pharma AG, Global Integrated Anal, Wuppertal, Germany
[8] Bayer Pharma AG, Med Affairs, Berlin, Germany
[9] McMaster Univ, Dept Med, Hamilton, ON, Canada
[10] St Georges Univ London, Cardiovasc & Cell Sci Res Inst, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P2606
引用
收藏
页码:512 / 513
页数:2
相关论文
共 50 条
  • [1] XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation
    Camm, A. John
    Amarenco, Pierre
    Haas, Sylvia
    Hess, Susanne
    Kirchhof, Paulus
    Kuhls, Silvia
    van Eickels, Martin
    Turpie, Alexander G. G.
    EUROPEAN HEART JOURNAL, 2016, 37 (14) : 1145 - 1153
  • [2] Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation: A Real-World Setting
    Fontaine, Gabriel V.
    Mathews, Katy D.
    Woller, Scott C.
    Stevens, Scott M.
    Lloyd, James F.
    Evans, R. Scott
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2014, 20 (07) : 665 - 672
  • [3] XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation (vol 37, pg 1145, 2016)
    Camm, A. John
    Amarenco, Pierre
    Haas, Sylvia
    Hess, Susanne
    Kirchhof, Paulus
    Kuhls, Silvia
    van Eickels, Martin
    Turpie, Alexander G. G.
    EUROPEAN HEART JOURNAL, 2024, 45 (20) : 1800 - 1800
  • [4] XANTUS, a prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation
    Postula, Marek
    Kosior, Dariusz
    KARDIOLOGIA POLSKA, 2015, 73 : 71 - 75
  • [5] Incidence of Major Bleeding in a Real-World Population of 57,070 Nonvalvular Atrial Fibrillation Patients Treated With Rivaroxaban
    Peacock, Frank
    Patel, Manesh
    Yuan, Zhong
    Sicignano, Nicholas
    Hopf, Kathleen
    Tamayo, Sally
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37
  • [6] XANAP: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Asia
    Kim, Young-Hoon
    Shim, Jaemin
    Tsai, Chia-Ti
    Wang, Chun-Chieh
    Vilela, Gilbert
    Muengtaweepongsa, Sombat
    Kurniawan, Mohammad
    Maskon, Oteh
    Hsu, Li Fern
    Thang Huy Nguyen
    Thanachartwet, Thititat
    Sim, Kenneth
    Camm, A. John
    JOURNAL OF ARRHYTHMIA, 2018, 34 (04) : 418 - 427
  • [7] Rates of major bleeding with rivaroxaban in real-world studies of nonvalvular atrial fibrillation patients: a meta-analysis
    Weeda, Erin R.
    White, C. Michael
    Peacock, W. Frank
    Coleman, Craig I.
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (06) : 1117 - 1120
  • [8] XANTUS-EL: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Eastern Europe, Middle East, Africa and Latin America
    Arean Martinez, Carlos Arturo
    Lanas, Fernando
    Radaideh, Ghazi
    Kharabsheh, Suleiman M.
    Lambelet, Marc
    Viaud, Marco Antonio Lavagnino
    Ziadeh, Naser Samih
    Turpie, Alexander G. G.
    EGYPTIAN HEART JOURNAL, 2018, 70 (04): : 307 - 313
  • [9] Gender and bleeding in atrial fibrillation: a real-world prospective cohort study
    Focks, J. J.
    Seelig, J.
    van Vugt, S. P.
    Serne, A. W.
    de Vries, L. B.
    Albers-Akkers, M. T.
    Verheugt, F. W.
    Brouwer, M. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 884 - 885
  • [10] REAL-WORLD VERSUS RANDOMIZED TRIAL OUTCOMES IN SIMILAR POPULATIONS OF RIVAROXABAN-TREATED PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION IN ROCKET AF AND XANTUS
    Camm, A. John
    Amarenco, Pierre
    Haas, Sylvia
    Hess, Susanne
    Kirchhof, Paulus
    Kuhls, Silvia
    Lambelet, Marc
    van Eickels, Martin
    Turpie, Alexander
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 438 - 438